A Phase I/II Pilot Study of the Safety of the Adoptive Transfer of Syngeneic Gene-Modified Cytotoxic T Lymphocytes in HIV-Infected Identical Twins. National Institutes of Health, Bethesda, Maryland

Abstract
No abstract available